Patent details

Basic Information

Publication number:

EP1572095

PCT Application Number:

PCT/US/2003/029017

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037703345

PCT Publication Number:

WO/2004/024095

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BETA-L-2'-DEOXYNUCLEOSIDES FOR USE IN THE TREATMENT OF RESISTANT HBV STRAINS

French Title of Invention:

BETA-L-2'-DESOXYNUCLEOSIDES POUR L'UTILISATION DANS LE TRAITEMENT DE SOUCHES DU VHB RESISTANTES

German Title of Invention:

BETA-L-2'-DESOXYNUCLEOSIDE ZUR VERWENDUNG IN DER BEHANDLUNG VON RESISTENTEN HBV-STÄMMEN

SPC Number:

Dates

Filing date:

15/09/2003

Grant date:

10/06/2015

EP Publication Date:

10/06/2015

PCT Publication Date:

25/03/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/09/2005

EP B1 Publication Date:

10/06/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/09/2022

Expiration date:

15/09/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/09/2003

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

SOMMADOSSI Jean-Pierre

Address:

United States (US)

2

Name:

SEIFFER Maria

Address:

United States (US)

3

Name:

PATTY April, L.

Address:

United States (US)

4

Name:

STANDRING David

Address:

United States (US)

Priority

Priority Number:

410675 P

Priority Date:

13/09/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/70;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/09/2021

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages